Dr. Reddy's to Release Q2 and Half Year FY14 Results on October 31, 2013

  Dr. Reddy's to Release Q2 and Half Year FY14 Results on October 31, 2013

    Earnings call slated for October 31, 2013 - 6.30 PM IST / 9.00 AM EDT*

Business Wire

HYDERABAD, India -- October 19, 2013

Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the Second
Quarter and Half Year ended September 30, 2013 on Thursday, October 31, 2013
after the Board Meeting. The results will be available on the Company’s
website www.drreddys.com

Summary of Events

                                                
Event                 Date and Time (IST)         Medium
Release of financial  October 31st, after the     Email, Media, Company
results                Board Meeting                website, Business Wire
                       October 31st, 6.30 PM IST    Hosted by the Company
Earnings Call         / 9:00 AM EDT              
                                                    (Details below)
Webcast of Earnings    October 31st, 6.30 PM IST    URL available on Company’s
Call                  / 9.00 AM EDT through       website, www.drreddys.com
                       November 5th, 2013
Transcripts of the    Will be available on the    URL available on Company’s
Earnings call          Company’s website            website, www.drreddys.com
                                                 

Earnings Call

Following the release, the management of the Company will host an earnings
call to discuss the Company’s financial performance.


Conference Dial-In Numbers
Primary Number:            +91 22 6629 0356
Secondary Number:          +91 22 3065 0136
The numbers listed above are universally accessible from all networks and all
countries.
                            6000 1221
                            Available in - Ahmedabad, Bangalore, Bhubaneswar,
                            Chandigarh, Chennai, Coimbatore, Delhi, Goa,
                            Guntur, Gurgaon, Hyderabad, Indore, Jamshedpur,
                            Kanpur, Kochi/Cochin, Kolhapur, Kolkata, Nagpur,
                            Noida, Patna, Pune, Raipur, Rajkot, Surat,
Local Access Number:       Trivandrum, Vadodara, Vijayawada
                            Accessible from all major carriers except
                            BSNL/MTNL.
                            3940 3977
                            Available in Ahmedabad, Bangalore, Chandigarh,
                            Chennai, Kochi/Cochin, Gurgaon (NCR), Hyderabad,
                            Kolkata, Lucknow, Pune
                            Accessible from all carriers.
                            USA: 1 866 746 2133
International Toll Free    UK: 0 808 101 1573
Number:                     Singapore: 800 101 2045
                            Hong Kong: 800 964 448
                            

No password/pin number is necessary to dial in to any of the other calls. As
participation in the call is limited, early registration is encouraged. The
operator will provide instructions on asking questions before and during the
call.

Audio Webcast

The audio webcast of the earnings call will be available to all interested
parties at www.drreddys.com. Please visit the web site at least fifteen
minutes ahead of the scheduled start time to register and to download and
install any necessary audio software. Participants in the webcast can listen
to the proceedings, but will not be able to ask questions. The replay will be
available 2 hours after the earnings call, through October 5th, 2013. For play
back dial in phone No: 022 3065 1212 and ID: 375#.

Transcript

The transcript of the earnings call will also be available on the Company's
website.

About Dr. Reddy’s

Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) is an integrated global
pharmaceutical company, committed to providing affordable and innovative
medicines for healthier lives. Through its three businesses - Pharmaceutical
Services and Active Ingredients, Global Generics and Proprietary Products –
Dr. Reddy’s offers a portfolio of products and services including APIs, custom
pharmaceutical services, generics, biosimilars and differentiated
formulations. Major therapeutic focus is on gastro-intestinal, cardiovascular,
diabetology, oncology, pain management and anti-infective. Major markets
include India, USA, Russia-CIS and Europe apart from other select geographies
within Emerging Markets.

For more information, log on to: www.drreddys.com

*EDT- Eastern Daylight Saving Time

Contact:

Dr. Reddy's Laboratories
Investor Relations
Kedar Upadhye, +91 40 66834297
kedaru@drreddys.com
or
Saunak Savla, +91 40 49002135
saunaks@drreddys.com
or
Milan Kalawadia (USA), +1 9082034931
mkalawadia@drreddys.com